Shionogi & Co., Ltd.
General ticker "SGIOF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $15.8B (TTM average)
Shionogi & Co., Ltd. does not follow the US Stock Market performance with the rate: -9.5%.
Estimated limits based on current volatility of 0.3%: low 16.33$, high 16.44$
Factors to consider:
- Company pays dividends (annually): last record date 2026-09-30, amount 0.24$ (Y1.46%)
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [11.99$, 17.07$]
- 2026-03-31 to 2027-03-31 estimated range: [12.16$, 17.35$]
Financial Metrics affecting the SGIOF estimates:
- Positive: with PPE of 8.8 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 29.40 > 24.19
- Positive: Operating profit margin, % of 35.73 > 33.79
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 9.99
- Negative: 0 < Inventory ratio change, % of 0.01
- Positive: -51.61 < Industry operating profit margin (median), % of -22.85
- Negative: Investing cash flow per share per price, % of -17.46 <= -11.23
Short-term SGIOF quotes
Long-term SGIOF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥426,684.00MM | ¥435,081.00MM | ¥438,268.00MM |
| Operating Expenses | ¥277,681.00MM | ¥281,771.00MM | ¥281,665.00MM |
| Operating Income | ¥149,003.00MM | ¥153,310.00MM | ¥156,603.00MM |
| Non-Operating Income | ¥71,329.00MM | ¥44,973.00MM | ¥44,147.00MM |
| Interest Expense | ¥4,500.00MM | ¥6,701.00MM | ¥9,027.00MM |
| R&D Expense | ¥102,392.00MM | ¥102,640.00MM | ¥108,612.00MM |
| Income(Loss) | ¥220,332.00MM | ¥198,283.00MM | ¥200,750.00MM |
| Taxes | ¥35,836.00MM | ¥37,708.00MM | ¥31,215.00MM |
| Net Income(Loss)* | ¥184,965.00MM | ¥162,030.00MM | ¥170,435.00MM |
| Stockholders Equity | ¥1,100,046.00MM | ¥1,235,326.00MM | ¥1,361,924.00MM |
| Inventory | ¥57,919.00MM | ¥64,916.00MM | ¥65,477.00MM |
| Assets | ¥1,311,800.00MM | ¥1,416,918.00MM | ¥1,535,349.00MM |
| Operating Cash Flow | ¥177,867.00MM | ¥154,284.00MM | ¥195,460.00MM |
| Capital expenditure | ¥37,187.00MM | ¥28,267.00MM | ¥52,103.00MM |
| Investing Cash Flow | ¥-48,292.00MM | ¥5,922.00MM | ¥-116,080.00MM |
| Financing Cash Flow | ¥-84,123.00MM | ¥-126,853.00MM | ¥-64,908.00MM |
| Earnings Per Share** | ¥621.31 | ¥558.32 | ¥600.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.